Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren's Disease
Authors:
Open Access
- 17 August 2012
- journal article
- retracted article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8) , e43406
Abstract
While Dupuytren's disease can cause disabling contractures requiring open surgery, a less-invasive option using Clostridium Histolyticum collagenase (CHC) via percutaneous injection was recently reported. A recent prospective, randomized trial demonstrated few complications during 90 days follow-up, however did not assess any longer term follow-up for these patients. Long-term outcomes in this setting have not been adequately reported, and the current manuscript aims to identify late complications from the clinical use of percutaneous CHC. The current manuscript reports an extended 12-month follow-up for a cohort of twelve of patients enrolled in the original prospective, randomized trial, treated at a single institution. An analysis of complications requiring surgical intervention was undertaken. Two of twelve patients reported debilitating pain and triggering requiring surgical intervention. Extensive deep-tissue scarring and adhesions were identified, providing the first visual and qualitative analysis of the pathologic effects of CHC. Late complications from CHC use can and have occurred, outside the follow-up period of the initial phase III trials. Longer term follow-up of such patients is thus essential, and further investigation and characterization of the late effects of CHC use is warranted.Keywords
This publication has 12 references indexed in Scilit:
- Collagenase clostridium histolyticum for Dupuytren's contractureExpert Opinion on Biological Therapy, 2010
- Injectable Collagenase Clostridium Histolyticum for Dupuytren's ContractureNew England Journal of Medicine, 2009
- Whatʼs New in Hand SurgeryJournal of Bone and Joint Surgery, 2009
- Epidemiological Evaluation of Dupuytren's Disease Incidence and Prevalence Rates in Relation to EtiologyHAND, 2009
- Efficacy and Safety of Injectable Mixed Collagenase Subtypes in the Treatment of Dupuytren’s ContractureThe Journal of Hand Surgery, 2007
- Dupuytren's contracture unfoldedBMJ, 2006
- Management of Dupuytren's Disease – Clear Advice for an Elusive ConditionThe Annals of The Royal College of Surgeons of England, 2006
- Collagen as a clinical target: Nonoperative treatment of Dupuytren's diseaseThe Journal of Hand Surgery, 2002
- Dupuytren's disease: an overview.2000
- Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potentialAntimicrobial Agents and Chemotherapy, 1992